The Molecular Breast Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Molecular Breast Imaging market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Molecular Breast Imaging global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Head Molecular Breast Imaging segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Molecular Breast Imaging include Dilon Technologies, CMR Naviscan, Digirad, GE, and Mayo Clinic, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Molecular Breast Imaging market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Head Molecular Breast Imaging
Dual Head Molecular Breast Imaging
Market segment by Application, can be divided into
Hospital
Diagnostic Center
Others
Market segment by players, this report covers
Dilon Technologies
CMR Naviscan
Digirad
GE
Mayo Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Molecular Breast Imaging product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Molecular Breast Imaging, with revenue, gross margin and global market share of Molecular Breast Imaging from 2019 to 2022.
Chapter 3, the Molecular Breast Imaging competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Molecular Breast Imaging market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Molecular Breast Imaging research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Molecular Breast Imaging
1.2 Classification of Molecular Breast Imaging by Type
1.2.1 Overview: Global Molecular Breast Imaging Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Molecular Breast Imaging Revenue Market Share by Type in 2021
1.2.3 Single Head Molecular Breast Imaging
1.2.4 Dual Head Molecular Breast Imaging
1.3 Global Molecular Breast Imaging Market by Application
1.3.1 Overview: Global Molecular Breast Imaging Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Global Molecular Breast Imaging Market Size & Forecast
1.5 Global Molecular Breast Imaging Market Size and Forecast by Region
1.5.1 Global Molecular Breast Imaging Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Molecular Breast Imaging Market Size by Region, (2017-2022)
1.5.3 North America Molecular Breast Imaging Market Size and Prospect (2017-2028)
1.5.4 Europe Molecular Breast Imaging Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Molecular Breast Imaging Market Size and Prospect (2017-2028)
1.5.6 South America Molecular Breast Imaging Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Molecular Breast Imaging Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Molecular Breast Imaging Market Drivers
1.6.2 Molecular Breast Imaging Market Restraints
1.6.3 Molecular Breast Imaging Trends Analysis
2 Company Profiles
2.1 Dilon Technologies
2.1.1 Dilon Technologies Details
2.1.2 Dilon Technologies Major Business
2.1.3 Dilon Technologies Molecular Breast Imaging Product and Solutions
2.1.4 Dilon Technologies Molecular Breast Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Dilon Technologies Recent Developments and Future Plans
2.2 CMR Naviscan
2.2.1 CMR Naviscan Details
2.2.2 CMR Naviscan Major Business
2.2.3 CMR Naviscan Molecular Breast Imaging Product and Solutions
2.2.4 CMR Naviscan Molecular Breast Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 CMR Naviscan Recent Developments and Future Plans
2.3 Digirad
2.3.1 Digirad Details
2.3.2 Digirad Major Business
2.3.3 Digirad Molecular Breast Imaging Product and Solutions
2.3.4 Digirad Molecular Breast Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Digirad Recent Developments and Future Plans
2.4 GE
2.4.1 GE Details
2.4.2 GE Major Business
2.4.3 GE Molecular Breast Imaging Product and Solutions
2.4.4 GE Molecular Breast Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 GE Recent Developments and Future Plans
2.5 Mayo Clinic
2.5.1 Mayo Clinic Details
2.5.2 Mayo Clinic Major Business
2.5.3 Mayo Clinic Molecular Breast Imaging Product and Solutions
2.5.4 Mayo Clinic Molecular Breast Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Mayo Clinic Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Breast Imaging Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Molecular Breast Imaging Players Market Share in 2021
3.2.2 Top 10 Molecular Breast Imaging Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Molecular Breast Imaging Players Head Office, Products and Services Provided
3.4 Molecular Breast Imaging Mergers & Acquisitions
3.5 Molecular Breast Imaging New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Molecular Breast Imaging Revenue and Market Share by Type (2017-2022)
4.2 Global Molecular Breast Imaging Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Molecular Breast Imaging Revenue Market Share by Application (2017-2022)
5.2 Global Molecular Breast Imaging Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Molecular Breast Imaging Revenue by Type (2017-2028)
6.2 North America Molecular Breast Imaging Revenue by Application (2017-2028)
6.3 North America Molecular Breast Imaging Market Size by Country
6.3.1 North America Molecular Breast Imaging Revenue by Country (2017-2028)
6.3.2 United States Molecular Breast Imaging Market Size and Forecast (2017-2028)
6.3.3 Canada Molecular Breast Imaging Market Size and Forecast (2017-2028)
6.3.4 Mexico Molecular Breast Imaging Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Molecular Breast Imaging Revenue by Type (2017-2028)
7.2 Europe Molecular Breast Imaging Revenue by Application (2017-2028)
7.3 Europe Molecular Breast Imaging Market Size by Country
7.3.1 Europe Molecular Breast Imaging Revenue by Country (2017-2028)
7.3.2 Germany Molecular Breast Imaging Market Size and Forecast (2017-2028)
7.3.3 France Molecular Breast Imaging Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Molecular Breast Imaging Market Size and Forecast (2017-2028)
7.3.5 Russia Molecular Breast Imaging Market Size and Forecast (2017-2028)
7.3.6 Italy Molecular Breast Imaging Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Molecular Breast Imaging Revenue by Type (2017-2028)
8.2 Asia-Pacific Molecular Breast Imaging Revenue by Application (2017-2028)
8.3 Asia-Pacific Molecular Breast Imaging Market Size by Region
8.3.1 Asia-Pacific Molecular Breast Imaging Revenue by Region (2017-2028)
8.3.2 China Molecular Breast Imaging Market Size and Forecast (2017-2028)
8.3.3 Japan Molecular Breast Imaging Market Size and Forecast (2017-2028)
8.3.4 South Korea Molecular Breast Imaging Market Size and Forecast (2017-2028)
8.3.5 India Molecular Breast Imaging Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Molecular Breast Imaging Market Size and Forecast (2017-2028)
8.3.7 Australia Molecular Breast Imaging Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Molecular Breast Imaging Revenue by Type (2017-2028)
9.2 South America Molecular Breast Imaging Revenue by Application (2017-2028)
9.3 South America Molecular Breast Imaging Market Size by Country
9.3.1 South America Molecular Breast Imaging Revenue by Country (2017-2028)
9.3.2 Brazil Molecular Breast Imaging Market Size and Forecast (2017-2028)
9.3.3 Argentina Molecular Breast Imaging Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Molecular Breast Imaging Revenue by Type (2017-2028)
10.2 Middle East & Africa Molecular Breast Imaging Revenue by Application (2017-2028)
10.3 Middle East & Africa Molecular Breast Imaging Market Size by Country
10.3.1 Middle East & Africa Molecular Breast Imaging Revenue by Country (2017-2028)
10.3.2 Turkey Molecular Breast Imaging Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Molecular Breast Imaging Market Size and Forecast (2017-2028)
10.3.4 UAE Molecular Breast Imaging Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Molecular Breast Imaging Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Molecular Breast Imaging Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Molecular Breast Imaging Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Molecular Breast Imaging Revenue (USD Million) by Region (2017-2022)
Table 5. Global Molecular Breast Imaging Revenue Market Share by Region (2023-2028)
Table 6. Dilon Technologies Corporate Information, Head Office, and Major Competitors
Table 7. Dilon Technologies Major Business
Table 8. Dilon Technologies Molecular Breast Imaging Product and Solutions
Table 9. Dilon Technologies Molecular Breast Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. CMR Naviscan Corporate Information, Head Office, and Major Competitors
Table 11. CMR Naviscan Major Business
Table 12. CMR Naviscan Molecular Breast Imaging Product and Solutions
Table 13. CMR Naviscan Molecular Breast Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Digirad Corporate Information, Head Office, and Major Competitors
Table 15. Digirad Major Business
Table 16. Digirad Molecular Breast Imaging Product and Solutions
Table 17. Digirad Molecular Breast Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. GE Corporate Information, Head Office, and Major Competitors
Table 19. GE Major Business
Table 20. GE Molecular Breast Imaging Product and Solutions
Table 21. GE Molecular Breast Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 23. Mayo Clinic Major Business
Table 24. Mayo Clinic Molecular Breast Imaging Product and Solutions
Table 25. Mayo Clinic Molecular Breast Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Global Molecular Breast Imaging Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 27. Global Molecular Breast Imaging Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 28. Breakdown of Molecular Breast Imaging by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Molecular Breast Imaging Players Head Office, Products and Services Provided
Table 30. Molecular Breast Imaging Mergers & Acquisitions in the Past Five Years
Table 31. Molecular Breast Imaging New Entrants and Expansion Plans
Table 32. Global Molecular Breast Imaging Revenue (USD Million) by Type (2017-2022)
Table 33. Global Molecular Breast Imaging Revenue Share by Type (2017-2022)
Table 34. Global Molecular Breast Imaging Revenue Forecast by Type (2023-2028)
Table 35. Global Molecular Breast Imaging Revenue by Application (2017-2022)
Table 36. Global Molecular Breast Imaging Revenue Forecast by Application (2023-2028)
Table 37. North America Molecular Breast Imaging Revenue by Type (2017-2022) & (USD Million)
Table 38. North America Molecular Breast Imaging Revenue by Type (2023-2028) & (USD Million)
Table 39. North America Molecular Breast Imaging Revenue by Application (2017-2022) & (USD Million)
Table 40. North America Molecular Breast Imaging Revenue by Application (2023-2028) & (USD Million)
Table 41. North America Molecular Breast Imaging Revenue by Country (2017-2022) & (USD Million)
Table 42. North America Molecular Breast Imaging Revenue by Country (2023-2028) & (USD Million)
Table 43. Europe Molecular Breast Imaging Revenue by Type (2017-2022) & (USD Million)
Table 44. Europe Molecular Breast Imaging Revenue by Type (2023-2028) & (USD Million)
Table 45. Europe Molecular Breast Imaging Revenue by Application (2017-2022) & (USD Million)
Table 46. Europe Molecular Breast Imaging Revenue by Application (2023-2028) & (USD Million)
Table 47. Europe Molecular Breast Imaging Revenue by Country (2017-2022) & (USD Million)
Table 48. Europe Molecular Breast Imaging Revenue by Country (2023-2028) & (USD Million)
Table 49. Asia-Pacific Molecular Breast Imaging Revenue by Type (2017-2022) & (USD Million)
Table 50. Asia-Pacific Molecular Breast Imaging Revenue by Type (2023-2028) & (USD Million)
Table 51. Asia-Pacific Molecular Breast Imaging Revenue by Application (2017-2022) & (USD Million)
Table 52. Asia-Pacific Molecular Breast Imaging Revenue by Application (2023-2028) & (USD Million)
Table 53. Asia-Pacific Molecular Breast Imaging Revenue by Region (2017-2022) & (USD Million)
Table 54. Asia-Pacific Molecular Breast Imaging Revenue by Region (2023-2028) & (USD Million)
Table 55. South America Molecular Breast Imaging Revenue by Type (2017-2022) & (USD Million)
Table 56. South America Molecular Breast Imaging Revenue by Type (2023-2028) & (USD Million)
Table 57. South America Molecular Breast Imaging Revenue by Application (2017-2022) & (USD Million)
Table 58. South America Molecular Breast Imaging Revenue by Application (2023-2028) & (USD Million)
Table 59. South America Molecular Breast Imaging Revenue by Country (2017-2022) & (USD Million)
Table 60. South America Molecular Breast Imaging Revenue by Country (2023-2028) & (USD Million)
Table 61. Middle East & Africa Molecular Breast Imaging Revenue by Type (2017-2022) & (USD Million)
Table 62. Middle East & Africa Molecular Breast Imaging Revenue by Type (2023-2028) & (USD Million)
Table 63. Middle East & Africa Molecular Breast Imaging Revenue by Application (2017-2022) & (USD Million)
Table 64. Middle East & Africa Molecular Breast Imaging Revenue by Application (2023-2028) & (USD Million)
Table 65. Middle East & Africa Molecular Breast Imaging Revenue by Country (2017-2022) & (USD Million)
Table 66. Middle East & Africa Molecular Breast Imaging Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Molecular Breast Imaging Picture
Figure 2. Global Molecular Breast Imaging Revenue Market Share by Type in 2021
Figure 3. Single Head Molecular Breast Imaging
Figure 4. Dual Head Molecular Breast Imaging
Figure 5. Molecular Breast Imaging Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Diagnostic Center Picture
Figure 8. Others Picture
Figure 9. Global Molecular Breast Imaging Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Molecular Breast Imaging Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Molecular Breast Imaging Revenue Market Share by Region (2017-2028)
Figure 12. Global Molecular Breast Imaging Revenue Market Share by Region in 2021
Figure 13. North America Molecular Breast Imaging Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Molecular Breast Imaging Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Molecular Breast Imaging Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Molecular Breast Imaging Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Molecular Breast Imaging Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Molecular Breast Imaging Market Drivers
Figure 19. Molecular Breast Imaging Market Restraints
Figure 20. Molecular Breast Imaging Market Trends
Figure 21. Dilon Technologies Recent Developments and Future Plans
Figure 22. CMR Naviscan Recent Developments and Future Plans
Figure 23. Digirad Recent Developments and Future Plans
Figure 24. GE Recent Developments and Future Plans
Figure 25. Mayo Clinic Recent Developments and Future Plans
Figure 26. Global Molecular Breast Imaging Revenue Share by Players in 2021
Figure 27. Molecular Breast Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 28. Global Top 3 Players Molecular Breast Imaging Revenue Market Share in 2021
Figure 29. Global Top 10 Players Molecular Breast Imaging Revenue Market Share in 2021
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 31. Global Molecular Breast Imaging Revenue Share by Type in 2021
Figure 32. Global Molecular Breast Imaging Market Share Forecast by Type (2023-2028)
Figure 33. Global Molecular Breast Imaging Revenue Share by Application in 2021
Figure 34. Global Molecular Breast Imaging Market Share Forecast by Application (2023-2028)
Figure 35. North America Molecular Breast Imaging Sales Market Share by Type (2017-2028)
Figure 36. North America Molecular Breast Imaging Sales Market Share by Application (2017-2028)
Figure 37. North America Molecular Breast Imaging Revenue Market Share by Country (2017-2028)
Figure 38. United States Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Molecular Breast Imaging Sales Market Share by Type (2017-2028)
Figure 42. Europe Molecular Breast Imaging Sales Market Share by Application (2017-2028)
Figure 43. Europe Molecular Breast Imaging Revenue Market Share by Country (2017-2028)
Figure 44. Germany Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Molecular Breast Imaging Sales Market Share by Type (2017-2028)
Figure 50. Asia-Pacific Molecular Breast Imaging Sales Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Molecular Breast Imaging Revenue Market Share by Region (2017-2028)
Figure 52. China Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Japan Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. South Korea Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. India Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Southeast Asia Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Australia Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South America Molecular Breast Imaging Sales Market Share by Type (2017-2028)
Figure 59. South America Molecular Breast Imaging Sales Market Share by Application (2017-2028)
Figure 60. South America Molecular Breast Imaging Revenue Market Share by Country (2017-2028)
Figure 61. Brazil Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Argentina Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Middle East and Africa Molecular Breast Imaging Sales Market Share by Type (2017-2028)
Figure 64. Middle East and Africa Molecular Breast Imaging Sales Market Share by Application (2017-2028)
Figure 65. Middle East and Africa Molecular Breast Imaging Revenue Market Share by Country (2017-2028)
Figure 66. Turkey Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Saudi Arabia Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. UAE Molecular Breast Imaging Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source